Reply to "Issues on results of the external quality assessment for proviral DNA testing of HIV-1 Tropism in the Maraviroc Switch collaborative study".
作者信息
Tu Elise, Swenson Luke C, Land Sally, Pett Sarah, Emery Sean, Marks Kat, Kelleher Anthony D, Kaye Steve, Kaiser Rolf, Schuelter Eugene, Harrigan Richard
机构信息
The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
出版信息
J Clin Microbiol. 2013 Dec;51(12):4287. doi: 10.1128/JCM.02207-13.
Abstract
摘要
相似文献
1
Reply to "Issues on results of the external quality assessment for proviral DNA testing of HIV-1 Tropism in the Maraviroc Switch collaborative study".对“马拉维若转换协作研究中HIV-1嗜性原病毒DNA检测的外部质量评估结果相关问题”的回复
J Clin Microbiol. 2013 Dec;51(12):4287. doi: 10.1128/JCM.02207-13.
2
Issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the Maraviroc Switch collaborative study.马拉维若转换协作研究中HIV-1嗜性原病毒DNA检测的外部质量评估结果相关问题
J Clin Microbiol. 2013 Dec;51(12):4285-6. doi: 10.1128/JCM.02124-13.
3
Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study.马拉维若治疗转换研究中外源基因 HIV 嗜性检测的质量评估结果。
J Clin Microbiol. 2013 Jul;51(7):2063-71. doi: 10.1128/JCM.00510-13. Epub 2013 Apr 17.
4
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.基于马拉维若治疗的选择压力下，HIV-1 原病毒 DNA 的进化。
J Antimicrob Chemother. 2012 Jun;67(6):1479-85. doi: 10.1093/jac/dks055. Epub 2012 Feb 23.
5
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.原病毒DNA基因分型检测以指导病毒血症阴性受试者开始使用马拉维若：PROTEST研究48周结果分析
HIV Med. 2017 Aug;18(7):482-489. doi: 10.1111/hiv.12479. Epub 2016 Dec 30.
6
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.从未接受过抗逆转录病毒治疗的急性和慢性感染患者的血浆 RNA 及前病毒 DNA 中配对的 HIV-1 辅助受体使用情况。
J Med Virol. 2015 Feb;87(2):315-22. doi: 10.1002/jmv.24036. Epub 2014 Aug 20.
7
HIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patients.HIV-1 嗜性：来自智利患者常规临床样本中 RNA 与前病毒 DNA 的比较。
Virol J. 2013 Oct 28;10:318. doi: 10.1186/1743-422X-10-318.
8
High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings.HIV-1 型 C 亚型的血浆病毒 RNA 和前病毒 DNA 中的基因型核心受体预测具有高度一致性：在资源有限的环境中使用全血 DNA 的意义。
J Antimicrob Chemother. 2013 Sep;68(9):2003-6. doi: 10.1093/jac/dkt138. Epub 2013 Apr 30.
9
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.基于 HIV-1 DNA 的基因分型检测作为评估 HIV-1 辅助受体使用情况的工具在临床实践中的应用：来自 DIVA 研究小组的结果。
Infection. 2014 Feb;42(1):61-71. doi: 10.1007/s15010-013-0510-3. Epub 2013 Oct 22.
10
Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.抑制性抗逆转录病毒疗法下 HIV 嗜性的动态变化：对病毒血症不可检测个体中嗜性检测的影响。
J Antimicrob Chemother. 2010 Jul;65(7):1493-6. doi: 10.1093/jac/dkq156. Epub 2010 May 20.
Zotero 插件